Osuke Arai
Papers
1
Total Citations
4
H-Index
1
About
Dr. Osuke Arai is a urologic oncologist whose research focuses on optimizing surgical outcomes for prostate cancer, particularly through robotic-assisted radical prostatectomy. His most cited work critically examines the therapeutic value of extended pelvic lymph node dissection (ePLND) in intermediate- to high-risk prostate cancer patients. In a landmark 2025 study, Dr. Arai and colleagues demonstrated that ePLND may not provide a significant biochemical recurrence benefit, challenging conventional surgical dogma and prompting a reevaluation of lymph node management strategies. This contribution, already garnering 4 citations shortly after publication, has important implications for reducing surgical morbidity without compromising oncologic control. Dr. Arai’s research sits at the intersection of precision oncology and minimally invasive surgery, aiming to refine risk stratification and personalize lymphadenectomy approaches. His work is particularly notable for addressing a long-standing controversy in urologic oncology, offering evidence that may spare patients from unnecessary extended dissections. As a rising voice in robotic prostate cancer surgery, Dr. Arai continues to shape clinical guidelines through rigorous comparative effectiveness research.
Research Focus
Key Achievements
Top Papers
- 1